ADRB2 and allergic disease: Given the ability of salmeterol to enhance allergic disease and its potential to alter β2-AR conformation (Fig 2a), we determined how salmeterol and other ligands influence activation of MAP kinases previously linked to β2-AR signaling using human A549 human lung epithelial adenocarcinoma cells, which express a functional β2-AR [54].